Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.

High mobility group box chromosomal protein 1 (HMGB-1) released from injured cells plays an important role in the development of arthritis. This study investigated the anti-angiogenic effects of cilostazol in collagen-induced arthritis (CIA) of mice, and the underlying mechanisms involved. The expre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hye Young Kim, So Youn Park, Sung Won Lee, Hye Rin Lee, Won Suk Lee, Byung Yong Rhim, Ki Whan Hong, Chi Dae Kim
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a71d53b9a2a34c67b6367024b5910bb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a71d53b9a2a34c67b6367024b5910bb7
record_format dspace
spelling oai:doaj.org-article:a71d53b9a2a34c67b6367024b5910bb72021-11-25T06:04:27ZInhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.1932-620310.1371/journal.pone.0104743https://doaj.org/article/a71d53b9a2a34c67b6367024b5910bb72014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25126750/?tool=EBIhttps://doaj.org/toc/1932-6203High mobility group box chromosomal protein 1 (HMGB-1) released from injured cells plays an important role in the development of arthritis. This study investigated the anti-angiogenic effects of cilostazol in collagen-induced arthritis (CIA) of mice, and the underlying mechanisms involved. The expressions of HIF-1α, VEGF, NF-κB p65 and SIRT1 in synovial fibroblasts obtained from rheumatoid arthritis (RA) patients were assessed by Western blotting, and in vitro and in vivo angiogenesis were analyzed. Tube formations by human microvascular endothelial cells (HMVECs) were significantly increased by direct exposure to HMGB1 or to conditioned medium derived from HMGB1-stimulated RA fibroblasts, and these increases were attenuated by cilostazol, the latter of which was blocked by sirtinol. HMGB1 increased the expression of HIF-1α and VEGF and concomitantly increased nuclear NF-κB p65 and DNA binding activity, but these effects of HMGB1 were inhibited by cilostazol. SIRT1 protein expression was time-dependently decreased (3-24 hr) by HMGB1, which was recovered by pretreatment with cilostazol (1-30 µM) or resveratrol, accompanying with increased SIRT1 deacetylase activity. In the tibiotarsal joint tissues of CIA mice treated with vehicle, HIF-1α- and VEGF-positive spots and CD31 staining were markedly exaggerated, whereas SIRT1 immunofluorescence was diminished. These variables were wholly reversed in cilostazol (30 mg/kg/day)-treated mice. Furthermore, number of blood vessels stained by von Willebrand factor antibody was significantly lower in cilostazol-treated CIA mice. Summarizing, cilostazol activated SIRT1 and inhibited NF-κB-mediated transcription, thereby suppressing the expression of HIF-1α and VEGF. In addition, cilostazol caused HIF-1α deacetylation by enhancing SIRT1 activity and reduced VEGF production, thereby had an anti-angiogenic effect in vitro studies and in CIA murine model.Hye Young KimSo Youn ParkSung Won LeeHye Rin LeeWon Suk LeeByung Yong RhimKi Whan HongChi Dae KimPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 8, p e104743 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Hye Young Kim
So Youn Park
Sung Won Lee
Hye Rin Lee
Won Suk Lee
Byung Yong Rhim
Ki Whan Hong
Chi Dae Kim
Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
description High mobility group box chromosomal protein 1 (HMGB-1) released from injured cells plays an important role in the development of arthritis. This study investigated the anti-angiogenic effects of cilostazol in collagen-induced arthritis (CIA) of mice, and the underlying mechanisms involved. The expressions of HIF-1α, VEGF, NF-κB p65 and SIRT1 in synovial fibroblasts obtained from rheumatoid arthritis (RA) patients were assessed by Western blotting, and in vitro and in vivo angiogenesis were analyzed. Tube formations by human microvascular endothelial cells (HMVECs) were significantly increased by direct exposure to HMGB1 or to conditioned medium derived from HMGB1-stimulated RA fibroblasts, and these increases were attenuated by cilostazol, the latter of which was blocked by sirtinol. HMGB1 increased the expression of HIF-1α and VEGF and concomitantly increased nuclear NF-κB p65 and DNA binding activity, but these effects of HMGB1 were inhibited by cilostazol. SIRT1 protein expression was time-dependently decreased (3-24 hr) by HMGB1, which was recovered by pretreatment with cilostazol (1-30 µM) or resveratrol, accompanying with increased SIRT1 deacetylase activity. In the tibiotarsal joint tissues of CIA mice treated with vehicle, HIF-1α- and VEGF-positive spots and CD31 staining were markedly exaggerated, whereas SIRT1 immunofluorescence was diminished. These variables were wholly reversed in cilostazol (30 mg/kg/day)-treated mice. Furthermore, number of blood vessels stained by von Willebrand factor antibody was significantly lower in cilostazol-treated CIA mice. Summarizing, cilostazol activated SIRT1 and inhibited NF-κB-mediated transcription, thereby suppressing the expression of HIF-1α and VEGF. In addition, cilostazol caused HIF-1α deacetylation by enhancing SIRT1 activity and reduced VEGF production, thereby had an anti-angiogenic effect in vitro studies and in CIA murine model.
format article
author Hye Young Kim
So Youn Park
Sung Won Lee
Hye Rin Lee
Won Suk Lee
Byung Yong Rhim
Ki Whan Hong
Chi Dae Kim
author_facet Hye Young Kim
So Youn Park
Sung Won Lee
Hye Rin Lee
Won Suk Lee
Byung Yong Rhim
Ki Whan Hong
Chi Dae Kim
author_sort Hye Young Kim
title Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
title_short Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
title_full Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
title_fullStr Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
title_full_unstemmed Inhibition of HMGB1-induced angiogenesis by cilostazol via SIRT1 activation in synovial fibroblasts from rheumatoid arthritis.
title_sort inhibition of hmgb1-induced angiogenesis by cilostazol via sirt1 activation in synovial fibroblasts from rheumatoid arthritis.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/a71d53b9a2a34c67b6367024b5910bb7
work_keys_str_mv AT hyeyoungkim inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT soyounpark inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT sungwonlee inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT hyerinlee inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT wonsuklee inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT byungyongrhim inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT kiwhanhong inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
AT chidaekim inhibitionofhmgb1inducedangiogenesisbycilostazolviasirt1activationinsynovialfibroblastsfromrheumatoidarthritis
_version_ 1718414238469324800